457 related articles for article (PubMed ID: 28436684)
21. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
[TBL] [Abstract][Full Text] [Related]
22. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gerber GS; Fitzpatrick JM
BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
[TBL] [Abstract][Full Text] [Related]
23. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
[TBL] [Abstract][Full Text] [Related]
24. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
Amdii RE; Al' Shukri AS
Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
[TBL] [Abstract][Full Text] [Related]
25. Serenoa repens (saw palmetto): a systematic review of adverse events.
Agbabiaka TB; Pittler MH; Wider B; Ernst E
Drug Saf; 2009; 32(8):637-47. PubMed ID: 19591529
[TBL] [Abstract][Full Text] [Related]
26. Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study.
Ryu YW; Lim SW; Kim JH; Ahn SH; Choi JD
Urol Int; 2015; 94(2):187-93. PubMed ID: 25614155
[TBL] [Abstract][Full Text] [Related]
27. Do we really need herbal medicine in LUTS/BPH treatment in the 21
Pinggera GM; Frauscher F
Expert Opin Drug Saf; 2016 Dec; 15(12):1573-1575. PubMed ID: 27461908
[No Abstract] [Full Text] [Related]
28. [Iscussion on the use of hexane extract of Serenoa repens for combination therapy in patients with LUTS/BPH].
Sivkov AV; Kirpatovskyi VI
Urologiia; 2021 Mar; (1):131-139. PubMed ID: 33818949
[TBL] [Abstract][Full Text] [Related]
29. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
De Nunzio C; Salonia A; Gacci M; Ficarra V
World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
[TBL] [Abstract][Full Text] [Related]
30. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.
De Monte C; Carradori S; Granese A; Di Pierro GB; Leonardo C; De Nunzio C
BMC Urol; 2014 Aug; 14():63. PubMed ID: 25112532
[TBL] [Abstract][Full Text] [Related]
31. Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia.
Saidi S; Stavridis S; Stankov O; Dohcev S; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):123-129. PubMed ID: 28991765
[TBL] [Abstract][Full Text] [Related]
32. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
Plosker GL; Brogden RN
Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
[TBL] [Abstract][Full Text] [Related]
33.
Trivisonno LF; Sgarbossa N; Alvez GA; Fieiras C; Escobar Liquitay CM; Jung JH; Franco JVA
Investig Clin Urol; 2021 Sep; 62(5):520-534. PubMed ID: 34488251
[TBL] [Abstract][Full Text] [Related]
34. Comparison of
Cai T; Cui Y; Yu S; Li Q; Zhou Z; Gao Z
Am J Mens Health; 2020; 14(2):1557988320905407. PubMed ID: 32274957
[TBL] [Abstract][Full Text] [Related]
35. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
[TBL] [Abstract][Full Text] [Related]
36. Re: Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and its Clinical Implications in Naturopathic Medicine.
Kaplan SA
J Urol; 2018 Jun; 199(6):1372-1373. PubMed ID: 29783548
[No Abstract] [Full Text] [Related]
37. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.
Koch E
Planta Med; 2001 Aug; 67(6):489-500. PubMed ID: 11509966
[TBL] [Abstract][Full Text] [Related]
38. Letter to the editorResponse to: Russo A, Capogrosso P, La Croce G, et al. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf. 2016 Jun;1:1-10.
Arena S
Expert Opin Drug Saf; 2016 Oct; 15(10):1449. PubMed ID: 27558894
[No Abstract] [Full Text] [Related]
39. An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study.
Cai T; Morgia G; Carrieri G; Terrone C; Imbimbo C; Verze P; Mirone V;
Arch Ital Urol Androl; 2013 Dec; 85(4):184-9. PubMed ID: 24399119
[TBL] [Abstract][Full Text] [Related]
40. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
Boyle P; Robertson C; Lowe F; Roehrborn C
BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
